Jian Zhou

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 61

Top Venues

Cell death & disease

Hepatology (Baltimore, Md.)

Nature communications

Nature metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Jia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, Xiao-Yong Huang, Chao Gao, Xiao-Jun Guo, Hai-Ying Zeng, Xu-Dong Qu, Yi Chen, Dong Wu, Yan-Zi Pei, Xian-Long Meng, Yi-Min Zheng, Chen Liang, Peng-Fei Zhang, Jia-Bin Cai, Zhen-Bin Ding, Guo-Huan Yang, Ning Ren, Cheng Huang, Xiao-Ying Wang, Qiang Gao, Qi-Man Sun, Ying-Hong Shi, Shuang-Jian Qiu, Ai-Wu Ke, Guo-Ming Shi, Jian Zhou, Yi-Di Sun, Jia Fan
Macro CD5L + deteriorates CD8 + T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma. Nature communications 15 (1) (2024)
Bisi Miao, Ling Ge, Chenxi He, Xinghao Wang, Jibo Wu, Xiang Li, Kun Chen, Jinkai Wan, Shenghui Xing, Lingnan Ren, Zhennan Shi, Shengnan Liu, Yajun Hu, Jiajia Chen, Yanyan Yu, Lijian Feng, Natasha M Flores, Zhihui Liang, Xinyi Xu, Ruoxin Wang, Jian Zhou, Jia Fan, Bin Xiang, En Li, Yuanhui Mao, Jingdong Cheng, Kehao Zhao, Pawel K Mazur, Jiabin Cai, Fei Lan
SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma. Cell research (2024)
Bao-Ye Sun, Zhu-Tao Wang, Ke-Zhu Chen, Yang Song, Jing-Fang Wu, Dai Zhang, Guo-Qiang Sun, Jian Zhou, Jia Fan, Bo Hu, Yong Yi, Shuang-Jian Qiu
Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma. Cell death discovery 10 (1) (2024)
Jia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, Xiao-Yong Huang, Chao Gao, Xiao-Jun Guo, Hai-Ying Zeng, Xu-Dong Qu, Yi Chen, Dong Wu, Yan-Zi Pei, Xian-Long Meng, Yi-Min Zheng, Chen Liang, Peng-Fei Zhang, Jia-Bin Cai, Zhen-Bin Ding, Guo-Huan Yang, Ning Ren, Cheng Huang, Xiao-Ying Wang, Qiang Gao, Qi-Man Sun, Ying-Hong Shi, Shuang-Jian Qiu, Ai-Wu Ke, Guo-Ming Shi, Jian Zhou, Yi-Di Sun, Jia Fan
Macro CD5L + deteriorates CD8 + T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma. Nature communications 15 (1) (2024)
Bao-Ye Sun, Zhu-Tao Wang, Ke-Zhu Chen, Yang Song, Jing-Fang Wu, Dai Zhang, Guo-Qiang Sun, Jian Zhou, Jia Fan, Bo Hu, Yong Yi, Shuang-Jian Qiu
Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma. Cell death discovery 10 (1) (2024)
Yueshuo Li, Chenxing Yang, Longlong Xie, Feng Shi, Min Tang, Xiangjian Luo, Na Liu, Xudong Hu, Yongwei Zhu, Ann M Bode, Qiang Gao, Jian Zhou, Jia Fan, Xuejun Li, Ya Cao
CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma. Cell death & disease 15 (1) (2024)
Bisi Miao, Ling Ge, Chenxi He, Xinghao Wang, Jibo Wu, Xiang Li, Kun Chen, Jinkai Wan, Shenghui Xing, Lingnan Ren, Zhennan Shi, Shengnan Liu, Yajun Hu, Jiajia Chen, Yanyan Yu, Lijian Feng, Natasha M Flores, Zhihui Liang, Xinyi Xu, Ruoxin Wang, Jian Zhou, Jia Fan, Bin Xiang, En Li, Yuanhui Mao, Jingdong Cheng, Kehao Zhao, Pawel K Mazur, Jiabin Cai, Fei Lan
SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma. Cell research 34 (9) (2024)
Jia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, Xiao-Yong Huang, Chao Gao, Xiao-Jun Guo, Hai-Ying Zeng, Xu-Dong Qu, Yi Chen, Dong Wu, Yan-Zi Pei, Xian-Long Meng, Yi-Min Zheng, Chen Liang, Peng-Fei Zhang, Jia-Bin Cai, Zhen-Bin Ding, Guo-Huan Yang, Ning Ren, Cheng Huang, Xiao-Ying Wang, Qiang Gao, Qi-Man Sun, Ying-Hong Shi, Shuang-Jian Qiu, Ai-Wu Ke, Guo-Ming Shi, Jian Zhou, Yi-Di Sun, Jia Fan
Macro CD5L + deteriorates CD8 + T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma. Nature communications 15 (1) (2024)
Bao-Ye Sun, Zhu-Tao Wang, Ke-Zhu Chen, Yang Song, Jing-Fang Wu, Dai Zhang, Guo-Qiang Sun, Jian Zhou, Jia Fan, Bo Hu, Yong Yi, Shuang-Jian Qiu
Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma. Cell death discovery 10 (1) (2024)
Yueshuo Li, Chenxing Yang, Longlong Xie, Feng Shi, Min Tang, Xiangjian Luo, Na Liu, Xudong Hu, Yongwei Zhu, Ann M Bode, Qiang Gao, Jian Zhou, Jia Fan, Xuejun Li, Ya Cao
CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma. Cell death & disease 15 (1) (2024)
Jiaqiang Ma, Yingcheng Wu, Lifeng Ma, Xupeng Yang, Tiancheng Zhang, Qiang Gao, Teng Li, Ke Gao, Xia Shen, Jian Lin, Yamin Chen, Xiaoshan Liu, Yuting Fu, Xixi Gu, Zechuan Chen, Shan Jiang, Dong-Ning Rao, Jiaomeng Pan, Shu Zhang, Jian Zhou, Chen Huang, Xianjun Yu, Jia Fan, Guoji Guo, Xiaoming Zhang, Qiang Gao
A blueprint for tumor-infiltrating B cells across human cancers. Science (New York, N.Y.) 384 (6695) (2024)
Jiaqiang Ma, Yingcheng Wu, Lifeng Ma, Xupeng Yang, Tiancheng Zhang, Qiang Gao, Teng Li, Ke Gao, Xia Shen, Jian Lin, Yamin Chen, Xiaoshan Liu, Yuting Fu, Xixi Gu, Zechuan Chen, Shan Jiang, Dong-Ning Rao, Jiaomeng Pan, Shu Zhang, Jian Zhou, Chen Huang, Xianjun Yu, Jia Fan, Guoji Guo, Xiaoming Zhang, Qiang Gao
A blueprint for tumor-infiltrating B cells across human cancers. Science (New York, N.Y.) 384 (6695) (2024)
Yueshuo Li, Chenxing Yang, Longlong Xie, Feng Shi, Min Tang, Xiangjian Luo, Na Liu, Xudong Hu, Yongwei Zhu, Ann M Bode, Qiang Gao, Jian Zhou, Jia Fan, Xuejun Li, Ya Cao
CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma. Cell death & disease 15 (1) (2024)
Yueshuo Li, Chenxing Yang, Longlong Xie, Feng Shi, Min Tang, Xiangjian Luo, Na Liu, Xudong Hu, Yongwei Zhu, Ann M Bode, Qiang Gao, Jian Zhou, Jia Fan, Xuejun Li, Ya Cao
CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma. Cell death & disease 15 (1) (2024)
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy 8 (1) (2023)
Jun Gao, Yuan Fang, Jiafeng Chen, Zheng Tang, Mengxin Tian, Xifei Jiang, Chenyang Tao, Run Huang, Gui-Qi Zhu, Weifeng Qu, Xiaoling Wu, Jian Zhou, Jia Fan, Weiren Liu, Ying-Hong Shi
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy. Oncogene (2023)
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy 8 (1) (2023)
Xiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, Jia-Cheng Lu, Chuan-Yuan Wei, Chao Gao, Yan-Zi Pei, Yi Chen, Qi-Man Sun, Jia-Bin Cai, Jian Zhou, Jia Fan, Ai-Wu Ke, Yujiang G Shi, Ying-Hao Shen, Peng-Fei Zhang, Guo-Ming Shi, Guo-Huan Yang
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell death & disease 14 (2) (2023)
Gui-Qi Zhu, Zheng Tang, Run Huang, Wei-Feng Qu, Yuan Fang, Rui Yang, Chen-Yang Tao, Jun Gao, Xiao-Ling Wu, Hai-Xiang Sun, Yu-Fu Zhou, Shu-Shu Song, Zhen-Bin Ding, Zhi Dai, Jian Zhou, Dan Ye, Duo-Jiao Wu, Wei-Ren Liu, Jia Fan, Ying-Hong Shi
CD36 + cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell discovery 9 (1) (2023)
Jie Hu, Wei-Feng Liu, Xiang-Yu Zhang, Guo-Ming Shi, Xin-Rong Yang, Kai-Qian Zhou, Bo Hu, Fei-Yu Chen, Cheng Zhou, Wan-Yee Lau, Jia Fan, Zheng Wang, Jian Zhou
Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1. Hepatology international (2023)
Xiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, Jia-Cheng Lu, Chuan-Yuan Wei, Chao Gao, Yan-Zi Pei, Yi Chen, Qi-Man Sun, Jia-Bin Cai, Jian Zhou, Jia Fan, Ai-Wu Ke, Yujiang G Shi, Ying-Hao Shen, Peng-Fei Zhang, Guo-Ming Shi, Guo-Huan Yang
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell death & disease 14 (2) (2023)
Pei-Yun Zhou, Cheng Zhou, Wei Gan, Zheng Tang, Bao-Ye Sun, Jin-Long Huang, Gao Liu, Wei-Ren Liu, Meng-Xin Tian, Xi-Fei Jiang, Han Wang, Chen-Yang Tao, Yuan Fang, Wei-Feng Qu, Run Huang, Gui-Qi Zhu, Cheng Huang, Xiu-Tao Fu, Zhen-Bin Ding, Qiang Gao, Jian Zhou, Ying-Hong Shi, Yong Yi, Jia Fan, Shuang-Jian Qiu
Single-cell and spatial architecture of primary liver cancer. Communications biology 6 (1) (2023)
Xifei Jiang, Wenjia Deng, Siyao Tao, Zheng Tang, Yuehong Chen, Mengxin Tian, Ting Wang, Chenyang Tao, Yize Li, Yuan Fang, Congying Pu, Jun Gao, Xiaomin Wang, Weifeng Qu, Xiameng Gai, Zhen-Bin Ding, Yixian Fu, Ying Zheng, Siyuwei Cao, Jian Zhou, Min Huang, Weiren Liu, Jun Xu, Jia Fan, Yinghong Shi
A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma. Cell discovery 9 (1) (2023)
Gui-Qi Zhu, Zheng Tang, Run Huang, Wei-Feng Qu, Yuan Fang, Rui Yang, Chen-Yang Tao, Jun Gao, Xiao-Ling Wu, Hai-Xiang Sun, Yu-Fu Zhou, Shu-Shu Song, Zhen-Bin Ding, Zhi Dai, Jian Zhou, Dan Ye, Duo-Jiao Wu, Wei-Ren Liu, Jia Fan, Ying-Hong Shi
CD36 + cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell discovery 9 (1) (2023)
Ming-Hao Xu, Cheng Huang, Mei-Ling Li, Xiao-Dong Zhu, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun, Ying-Hao Shen
Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort study. Cancer medicine (2023)
Zijian Yang, Cong Yan, Jiaqiang Ma, Panpan Peng, Xuelian Ren, Shangli Cai, Xia Shen, Yingcheng Wu, Shu Zhang, Xiaoying Wang, Shuangjian Qiu, Jian Zhou, Jia Fan, He Huang, Qiang Gao
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nature metabolism 5 (1) (2023)
Zijian Yang, Cong Yan, Jiaqiang Ma, Panpan Peng, Xuelian Ren, Shangli Cai, Xia Shen, Yingcheng Wu, Shu Zhang, Xiaoying Wang, Shuangjian Qiu, Jian Zhou, Jia Fan, He Huang, Qiang Gao
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nature metabolism 5 (1) (2023)
Mao Zhang, Yingying Huang, Jiaomeng Pan, Chen Sang, Youpei Lin, Liangqing Dong, Xia Shen, Yingcheng Wu, Qiang Gao, Shuyi Ji, Fen Liu, Mengcheng Wang, Yuyan Zheng, Sirui Zhang, Zefeng Wang, Jianke Ren, Daming Gao, Jian Zhou, Jia Fan, Wu Wei, Jian Lin, Qiang Gao
An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma. Cancer discovery (2023)
Zijian Yang, Cong Yan, Jiaqiang Ma, Panpan Peng, Xuelian Ren, Shangli Cai, Xia Shen, Yingcheng Wu, Shu Zhang, Xiaoying Wang, Shuangjian Qiu, Jian Zhou, Jia Fan, He Huang, Qiang Gao
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nature metabolism 5 (1) (2023)
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy 8 (1) (2023)
Xiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, Jia-Cheng Lu, Chuan-Yuan Wei, Chao Gao, Yan-Zi Pei, Yi Chen, Qi-Man Sun, Jia-Bin Cai, Jian Zhou, Jia Fan, Ai-Wu Ke, Yujiang G Shi, Ying-Hao Shen, Peng-Fei Zhang, Guo-Ming Shi, Guo-Huan Yang
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell death & disease 14 (2) (2023)
Zijian Yang, Cong Yan, Jiaqiang Ma, Panpan Peng, Xuelian Ren, Shangli Cai, Xia Shen, Yingcheng Wu, Shu Zhang, Xiaoying Wang, Shuangjian Qiu, Jian Zhou, Jia Fan, He Huang, Qiang Gao
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nature metabolism 5 (1) (2023)
Zijian Yang, Cong Yan, Jiaqiang Ma, Panpan Peng, Xuelian Ren, Shangli Cai, Xia Shen, Yingcheng Wu, Shu Zhang, Xiaoying Wang, Shuangjian Qiu, Jian Zhou, Jia Fan, He Huang, Qiang Gao
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nature metabolism 5 (1) (2023)
Gui-Qi Zhu, Zheng Tang, Run Huang, Wei-Feng Qu, Yuan Fang, Rui Yang, Chen-Yang Tao, Jun Gao, Xiao-Ling Wu, Hai-Xiang Sun, Yu-Fu Zhou, Shu-Shu Song, Zhen-Bin Ding, Zhi Dai, Jian Zhou, Dan Ye, Duo-Jiao Wu, Wei-Ren Liu, Jia Fan, Ying-Hong Shi
CD36 + cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell discovery 9 (1) (2023)
Xiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, Jia-Cheng Lu, Chuan-Yuan Wei, Chao Gao, Yan-Zi Pei, Yi Chen, Qi-Man Sun, Jia-Bin Cai, Jian Zhou, Jia Fan, Ai-Wu Ke, Yujiang G Shi, Ying-Hao Shen, Peng-Fei Zhang, Guo-Ming Shi, Guo-Huan Yang
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell death & disease 14 (2) (2023)
Zijian Yang, Cong Yan, Jiaqiang Ma, Panpan Peng, Xuelian Ren, Shangli Cai, Xia Shen, Yingcheng Wu, Shu Zhang, Xiaoying Wang, Shuangjian Qiu, Jian Zhou, Jia Fan, He Huang, Qiang Gao
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nature metabolism (2023)
Liang Wu, Jiayan Yan, Yinqi Bai, Feiyu Chen, Xuanxuan Zou, Jiangshan Xu, Ao Huang, Liangzhen Hou, Yu Zhong, Zehua Jing, Qichao Yu, Xiaorui Zhou, Zhifeng Jiang, Chunqing Wang, Mengnan Cheng, Yuan Ji, Yingyong Hou, Rongkui Luo, Qinqin Li, Liang Wu, Jianwen Cheng, Pengxiang Wang, Dezhen Guo, Waidong Huang, Junjie Lei, Shang Liu, Yizhen Yan, Yiling Chen, Sha Liao, Yuxiang Li, Haixiang Sun, Na Yao, Xiangyu Zhang, Shiyu Zhang, Xi Chen, Yang Yu, Yao Li, Fengming Liu, Zheng Wang, Shaolai Zhou, Huanming Yang, Shuang Yang, Xue Liu, Longqi Liu, Qiang Gao, Zhaoyou Tang, Xiangdong Wang, Jian Wang, Jia Fan, Shi-Ping Liu, Xin-Rong Yang, Ao Chen, Jian Zhou
An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression. Cell research (2023)
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy 8 (1) (2023)
Xifei Jiang, Wenjia Deng, Siyao Tao, Zheng Tang, Yuehong Chen, Mengxin Tian, Ting Wang, Chenyang Tao, Yize Li, Yuan Fang, Congying Pu, Jun Gao, Xiaomin Wang, Weifeng Qu, Xiameng Gai, Zhen-Bin Ding, Yixian Fu, Ying Zheng, Siyuwei Cao, Jian Zhou, Min Huang, Weiren Liu, Jun Xu, Jia Fan, Yinghong Shi
A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma. Cell discovery 9 (1) (2023)
Xiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, Jia-Cheng Lu, Chuan-Yuan Wei, Chao Gao, Yan-Zi Pei, Yi Chen, Qi-Man Sun, Jia-Bin Cai, Jian Zhou, Jia Fan, Ai-Wu Ke, Yujiang G Shi, Ying-Hao Shen, Peng-Fei Zhang, Guo-Ming Shi, Guo-Huan Yang
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell death & disease 14 (2) (2023)
Yuan Fang, Weiren Liu, Zheng Tang, Xiang Ji, Yufu Zhou, Shushu Song, Mengxin Tian, Chenyang Tao, Run Huang, Guiqi Zhu, Xifei Jiang, Jun Gao, Weifeng Qu, Han Wang, Peiyun Zhou, Xiaoling Wu, Lei Jin, Haixiang Sun, Zhenbin Ding, Yuanfei Peng, Shimin Zhao, Jian Zhou, Jia Fan, Wei Xu, Ying-Hong Shi
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack. Hepatology (Baltimore, Md.) (2022)
Jian Zhou, Shao-Lai Zhou, Chubin Luo
Reply. Hepatology (Baltimore, Md.) 76 (2) (2022)
Xiangyu Zhang, Zheng Wang, Wanxiangfu Tang, Xinyu Wang, Rui Liu, Hua Bao, Xin Chen, Yulin Wei, Shuyu Wu, Hairong Bao, Xue Wu, Yang Shao, Jia Fan, Jian Zhou
Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics. Hepatology (Baltimore, Md.) 76 (2) (2022)
Jiafeng Chen, Zheng Gao, Xiaogang Li, Ying-Hong Shi, Zheng Tang, Weiren Liu, Xin Zhang, Ao Huang, Xuanming Luo, Qiang Gao, Guangyu Ding, Kang Song, Jian Zhou, Jia Fan, Xiutao Fu, Zhenbin Ding
SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance. Cancer medicine (2022)
Shao-Lai Zhou, Zheng-Jun Zhou, Cheng-Li Song, Hao-Yang Xin, Zhi-Qiang Hu, Chu-Bin Luo, Yi-Jie Luo, Jia Li, Zhi Dai, Xin-Rong Yang, Ying-Hong Shi, Zheng Wang, Xiao-Wu Huang, Jia Fan, Jian Zhou
Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence. Signal transduction and targeted therapy 7 (1) (2022)
Ao Huang, Jia-Feng Chen, Jian-Zhang Wu, Zheng Gao, Ying-Hong Shi, Xiu-Tao Fu, Xin Zhang, Wei-Ren Liu, Qiang Gao, Hui-Chuan Sun, Guo-Ming Shi, Jia Fan, Zhen-Bin Ding, Jian Zhou
Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges. Journal of oncology 2022 (2022)
Guo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, Tian-Qiang Song, Ming Kuang, Hai-Bo Mou, Le-Qun Bao, Hai-Tao Zhao, Haitao Zhao, Xie-Lin Feng, Bi-Xiang Zhang, Tao Peng, Yu-Bao Zhang, Xiang-Cheng Li, Hong-Sheng Yu, Yu Cao, Lian-Xin Liu, Ti Zhang, Wei-Lin Wang, Jiang-Hua Ran, Ying-Bin Liu, Wei Gong, Ming-Xia Chen, Lian Cao, Yang Luo, Yan Wang, Hui Zhou, Guo-Huan Yang, Jia Fan, Jian Zhou
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study. Cancer medicine (2022)
Zhou Lu, Ronghua Liu, Yining Wang, Mengxia Jiao, Zhongchen Li, Zhiqiang Wang, Cheng Huang, Guoming Shi, Aiwu Ke, Luman Wang, Ying Fu, Jie Xia, Haoyu Wen, Jian Zhou, Xiaoying Wang, Dan Ye, Jia Fan, Yiwei Chu, Jiabin Cai
Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma. Hepatology (Baltimore, Md.) (2022)
Zhenbin Ding, Hong Wu, Yongyi Zeng, Ming Kuang, Wei Yang, Zhiqiang Meng, Yajin Chen, Chunyi Hao, Shubing Zou, Huichuan Sun, Chang Liu, Kecan Lin, Guoming Shi, Xiaoying Wang, Xiutao Fu, Rongxin Chen, Yi Chen, Ruifang Liang, Takeshi Kano, Huiyan Pan, Suna Yang, Jia Fan, Jian Zhou
Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures. Hepatology international (2022)
Qiang Gao, Yang Shi, Lu Meng, Jiaqiang Ma, Siyuan Huang, Juan Zhang, Yingcheng Wu, Jiaxin Li, Youpei Lin, Shuaixi Yang, Dongning Rao, Yifei Cheng, Jian Lin, Shuyi Ji, Yuming Liu, Shan Jiang, Xiaoliang Wang, Shu Zhang, Aiwu Ke, Xiaoying Wang, Ya Cao, Yuan Ji, Jian Zhou, Jia Fan, Xiaoming Zhang, Ruibin Xi, Qiang Gao
Publisher Correction: Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma. Nature communications 13 (1) (2022)
Min Tang, Xin Dong, Lanbo Xiao, Zheqiong Tan, Xiangjian Luo, Lifang Yang, Wei Li, Feng Shi, Yueshuo Li, Lin Zhao, Na Liu, Qianqian Du, Longlong Xie, Jianmin Hu, Xinxian Weng, Jia Fan, Jian Zhou, Qiang Gao, Weizhong Wu, Xin Zhang, Weihua Liao, Ann M Bode, Ya Cao
CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma. Cell death & disease 13 (4) (2022)
Hua Zhang, Lin Zhao, Jingjing Jiang, Jie Zheng, Li Yang, Yanyan Li, Jian Zhou, Tianshu Liu, Jianmin Xu, Wenhui Lou, Weige Yang, Lijie Tan, Weiren Liu, Yiyi Yu, Meiling Ji, Yaolin Xu, Yan Lu, Xiaomu Li, Zhen Liu, Rong Tian, Cheng Hu, Shumang Zhang, Qinsheng Hu, Yangdong Deng, Hao Ying, Sheng Zhong, Xingdong Zhang, Yun-Bing Wang, Hua Wang, Jingwei Bai, Xiaoying Li, Xiangfeng Duan
Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification. Nature communications 13 (1) (2022)
Mengjie Deng, Peng Ran, Lingli Chen, Yunzhi Wang, Zixiang Yu, Ke Cai, Jinwen Feng, Zhaoyu Qin, Yanan Yin, Subei Tan, Yang Liu, Chen Xu, Guoming Shi, Yuan Ji, Jian-Yuan Zhao, Jian Zhou, Jia Fan, Yingyong Hou, Chen Ding
Proteogenomic characterization of cholangiocarcinoma. Hepatology (Baltimore, Md.) (2022)
Qiang Gao, Yang Shi, Lu Meng, Jiaqiang Ma, Siyuan Huang, Juan Zhang, Yingcheng Wu, Jiaxin Li, Youpei Lin, Shuaixi Yang, Dongning Rao, Yifei Cheng, Jian Lin, Shuyi Ji, Yuming Liu, Shan Jiang, Xiaoliang Wang, Shu Zhang, Aiwu Ke, Xiaoying Wang, Ya Cao, Yuan Ji, Jian Zhou, Jia Fan, Xiaoming Zhang, Ruibin Xi, Qiang Gao
Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma. Nature communications 13 (1) (2022)
Youpei Lin, Lihua Peng, Liangqing Dong, Dong-Bing Liu, Jiaqiang Ma, Jian Lin, Xiaofang Chen, Penghui Lin, Qiang Gao, Mao Zhang, Yuming Liu, Junhua Rao, Chen Wei, Ye Lu, Shu Zhang, Guangyu Ding, Zhenyu Peng, Haorong Lu, Xiao-Ying Wang, Jian Zhou, Jia Fan, Kui Wu, Qiang Gao
Geospatial Immune Heterogeneity Reflects the Diverse Tumor-Immune Interactions in Intrahepatic Cholangiocarcinoma. Cancer discovery 12 (10) (2022)
Chubin Luo, Haoyang Xin, Zhengjun Zhou, Zhiqiang Hu, Rongqi Sun, Na Yao, Qiman Sun, Uyunbilig Borjigin, Xia Wu, Jia Fan, Xiaowu Huang, Shao-Lai Zhou, Jian Zhou
Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression. Hepatology (Baltimore, Md.) 76 (4) (2022)
Shao-Lai Zhou, Chu-Bin Luo, Cheng-Li Song, Zheng-Jun Zhou, Hao-Yang Xin, Zhi-Qiang Hu, Rong-Qi Sun, Jia Fan, Jian Zhou
Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md.) (2021)
De-Zhen Guo, Ao Huang, Yu-Peng Wang, Ya Cao, Jia Fan, Xin-Rong Yang, Jian Zhou
Development of an Eight-gene Prognostic Model for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Journal of clinical and translational hepatology 9 (6) (2021)
Yun-Fan Sun, Liang Wu, Shi-Ping Liu, Miao-Miao Jiang, Bo Hu, Kai-Qian Zhou, Wei Guo, Yang Xu, Yu Zhong, Xiao-Rui Zhou, Ze-Fan Zhang, Geng Liu, Sheng Liu, Ying-Hong Shi, Yuan Ji, Min Du, Nan-Nan Li, Gui-Bo Li, Zhi-Kun Zhao, Xiao-Yun Huang, Li-Qin Xu, Qi-Chao Yu, David H Peng, Shuang-Jian Qiu, Hui-Chuan Sun, Michael Dean, Xiang-Dong Wang, Wen-Yuan Chung, Ashley R Dennison, Jian Zhou, Yong Hou, Jia Fan, Xin-Rong Yang
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma. Nature communications 12 (1) (2021)
Guo-Ming Shi, Jiping Wang, Xiao-Wu Huang, Xiao-Yong Huang, Yi-Feng He, Yuan Ji, Yi Chen, Dong Wu, Jia-Cheng Lu, Qi-Man Sun, Wei-Ren Liu, Ting Wang, Liu-Xiao Yang, Ying-Yong Hou, Ying-Hong Shi, Jian Sun, Yong-Sheng Xiao, Zheng Wang, Jia Fan, Monica M Bertagnolli, Jian Zhou
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 27 (3) (2020)
Yang Gao, Peng-Xiang Wang, Jian-Wen Cheng, Yun-Fan Sun, Bo Hu, Wei Guo, Kai-Qian Zhou, Yue Yin, Yuan-Cheng Li, Jian Wang, Jun-Feng Huang, Shuang-Jian Qiu, Jian Zhou, Jia Fan, Xin-Rong Yang
Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis. Cancer medicine 8 (16) (2019)

Jian Zhou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jian Zhou